News
| China Biotech in Review: Innovation Dominates the News (December 15, 2008) BioDuro, which established its Beijing lab in 2005, now has 550 employees on site. Through its relationship with NCSED, BioDuro is able to provide integrated research services from discovery to first-in-human. |
| BioDuro Labs Accredited by AAALAC (December 11, 2008) BioDuro, a CRO headquartered in San Diego, Calif., with laboratories in Beijing, China, announced that it has been awarded full accreditation from AAALAC. The same accreditation has been given to the labs of the National Center for Safety Evaluation of Drugs (NCSED), with whom BioDuro has an exclusive collaboration. |
| China's One-Stop Research Shop (May 19, 2008) "But the best thing about doing research in China is the scientists. They have a real thirst for knowledge, and an incredibly humble, yet can-do approach to challenges. There is nothing that they cannot learn and no challenge that cannot be overcome." |
| Biotech Entrepreneurs Grow a New CRO in China (May 19, 2008) Biotech entrepreneur John Oyler discusses BioDuro in a Chemistry World article. |
| China's Pharma Leaps into Discovery (February 4, 2008) "Three years ago, a lot of people were skeptical about the integrated nature of the work we were doing," says John V. Oyler, the chief executive officer of BioDuro, a supplier of drug discovery and development services with integrated capabilities in chemistry and biology. Although BioDuro is based in California, the bulk of its operations are located in Beijing. |
| San Diego Biotechs Find Partners Across Pacific (December 16, 2007) The San Diego-based company BioDuro also moved quickly to profit from China's biotech abilities. Entrepreneur Masood Tayebi saw how outsourcing in China could help cash-strapped U.S. biotechnology companies. |
| Shopping the World (November 26, 2007) John V. Oyler, chief executive officer of Beijing-based contract research firm BioDuro, tells C&EN that it's efficient for customers to work with an external partner that can provide chemistry as well as biology services at the same location. |
| BioDuro's Pitch Is That It Can Increase the Odds of Success (August 1, 2008) BioDuro's pitch is that it can increase the odds of success for early-stage biotech companies by allowing them to outsource chemistry and clinical functions. BioDuro can test several compounds for the same cost as testing one. |